Mel J. Yeates
This person does not yet have a bio.
Articles by Mel J. Yeates
| 4 min read
High tumor mutation burden can predict immunotherapy response only in subset of cancers
| 3 min read
New collaborations will give I-Mab access to cutting edge technology platforms for developing novel drug molecules
| 3 min read
Selexis and BITT enter agreement to advance BITT’s TNFR2 antagonist antibody therapy
| 2 min read
Akari Therapeutics enters agreement with US Army Institute of Surgical Research for nomacopan
| 3 min read
Oncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma
| 2 min read
Thermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform
| 3 min read
AI collaboration seeks to improve access to COVID-19 datasets across institutions
| 3 min read
Data show that roflumilast foam provides significant improvement for seborrheic dermatitis
| 3 min read
Clinical trial data demonstrate potential for BD Libertas wearable drug delivery system
| 3 min read
DIOS-202 and DIOS-203 have been engineered for high potency and potential for avoiding escape mutants
| 3 min read
NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
| 3 min read
BD has partnered with Scanwell Health for an at-home rapid test for COVID-19
